These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 217078)

  • 1. [Experimental neuropathy due to acrilamide. Histological and ultrastructural studies (author's transl)].
    Simonati A; Terzian H; Rizzuto N
    Riv Patol Nerv Ment; 1978 Sep; 98(4):213-27. PubMed ID: 217078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):276-99. PubMed ID: 190357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and morphological findings in acrylamide toxicity.
    Le Quesne PM
    Neurotoxicology; 1985; 6(4):17-24. PubMed ID: 4088539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow recovery of central axons in acrylamide neuropathy.
    Kaji R; Liu Y; Duckett S; Sumner AJ
    Muscle Nerve; 1989 Oct; 12(10):816-26. PubMed ID: 2558312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nervous system degeneration produced by acrylamide monomer.
    Spencer PS; Schaumburg HH
    Environ Health Perspect; 1975 Jun; 11():129-33. PubMed ID: 170076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphology of carbon disulfide neurotoxicity.
    Gottfried MR; Graham DG; Morgan M; Casey HW; Bus JS
    Neurotoxicology; 1985; 6(4):89-96. PubMed ID: 3003629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural changes in the peripheral nerves in experimental dying-back polyneuropathies.
    Prineas JW
    Proc Aust Assoc Neurol; 1971; 8():121-3. PubMed ID: 4341115
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbon disulfide neurotoxicity in rats: V. Morphology of axonal swelling in the muscular branch of the posterior tibial nerve and spinal cord.
    Sills RC; Harry GJ; Morgan DL; Valentine WM; Graham DG
    Neurotoxicology; 1998 Feb; 19(1):117-27. PubMed ID: 9498228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental lead neuropathy: a disease of the supporting cells in the peripheral nervous system.
    Schlaepfer WW
    J Neuropathol Exp Neurol; 1969 Jul; 28(3):401-18. PubMed ID: 4307024
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene probe for P0 messenger RNA used to index acrylamide toxic neuropathy in rats.
    Veronesi B; Jones K; Gupta S; Pringle J; Mezei C
    Neurotoxicology; 1991; 12(4):715-32. PubMed ID: 1724557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport.
    Sickles DW
    Neurotoxicology; 1989; 10(1):91-101. PubMed ID: 2475836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed onset of distal axonal neuropathy in primates after prolonged low-level administration of a neurotoxin.
    Schaumburg HH; Arezzo JC; Spencer PS
    Ann Neurol; 1989 Oct; 26(4):576-9. PubMed ID: 2817831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The early phase of vincristine-induced neuropathy. Electrophysiological evidence of a "dying-back" phenomenon (author's transl)].
    Sebille A; Parlier Y
    Nouv Presse Med; 1981 Jul; 10(29):2417-20. PubMed ID: 6265865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral nerve pathology of experimental lead neuropathy (author's transl)].
    Matsuoka Y; Sobue I
    Rinsho Shinkeigaku; 1981 Jan; 21(1):56-63. PubMed ID: 6265133
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for direct axonal toxicity in vincristine neuropathy.
    Silva A; Wang Q; Wang M; Ravula SK; Glass JD
    J Peripher Nerv Syst; 2006 Sep; 11(3):211-6. PubMed ID: 16930282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurotoxic substances as a tool to understand some mechanisms of peripheral neuropathies (author's transl)].
    Sebille A; Hugelin A
    Pathol Biol (Paris); 1982 Jan; 30(1):37-41. PubMed ID: 6174920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peripheral neuropathies. Current data concerning nerve regeneration (author's transl)].
    Sebille A
    Nouv Presse Med; 1982 Apr; 11(16):1206-15. PubMed ID: 6285276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model.
    George R; Griffin JW
    Exp Neurol; 1994 Oct; 129(2):225-36. PubMed ID: 7957737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cis-platinum-induced peripheral neuropathy. One case (author's transl)].
    Gastaut JL; Pellissier JF; Jean P; Tubiana N; Carcassonne Y
    Nouv Presse Med; 1982 Apr; 11(15):1113-7. PubMed ID: 6281722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.